Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
Guidance Documents/Guidance-Document/Benefit-Risk Considerations for Product Quality Assessments

Benefit-Risk Considerations for Product Quality Assessments

Detailed guidance document from FDA and regulatory agencies.

Document Details

Guidance Document

May 9, 2022

May 10, 2022

Center for Drug Evaluation and Research

dd4547d7-4ac9-437a-8d9b-b88b234da4bc

Related Documents

Establishing Impurity Specifications for Antibiotics

Guidance DocumentApril 20, 2026Center for Drug Evaluation and Research
View Details →

Quality Considerations for Topical Ophthalmic Drug Products

Guidance DocumentDecember 27, 2023Center for Drug Evaluation and Research
View Details →

How To Obtain a Covered Product Authorization

Guidance DocumentSeptember 21, 2022Center for Drug Evaluation and Research
View Details →

Quick Actions

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Transform Regulatory Data into Actionable Intelligence

Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.

KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.